| 东阳光长江药业 |
Morgan Stanley |
增持 |
6925485 |
2679.67万股 |
0.06% |
好仓 |
2020-07-10 |
| 中信证券 |
Citigroup Inc. |
减持 |
-55341943 |
13143.07万股 |
0.06% |
好仓 |
2020-07-10 |
| 捷利交易宝 |
VMI Capital Group Limited |
减持 |
-56150000 |
0.00万股 |
0.00% |
好仓 |
2020-07-10 |
| 海普瑞 |
UBS Group AG |
减持 |
-6921500 |
649.60万股 |
0.03% |
好仓 |
2020-07-10 |
| 海普瑞 |
UBS AG |
减持 |
-6921500 |
518.90万股 |
0.02% |
好仓 |
2020-07-10 |
| 华领医药-B |
JohnsonAbigail P. |
减持 |
-12670000 |
8274.49万股 |
0.08% |
好仓 |
2020-07-10 |
| 华领医药-B |
Johnson IVEdward C. |
减持 |
-12670000 |
8274.49万股 |
0.08% |
好仓 |
2020-07-10 |
| 维亚生物 |
China International Capital Corporation Limited |
减持 |
-91000000 |
490.87万股 |
0.00% |
好仓 |
2020-07-10 |
| 维亚生物 |
China International Capital Corporation (Hong Kong) Limited |
减持 |
-91000000 |
380.82万股 |
0.00% |
好仓 |
2020-07-10 |
| 华领医药-B |
FMR LLC |
减持 |
-12670000 |
10217.64万股 |
0.10% |
好仓 |
2020-07-10 |
| 华领医药-B |
FMR LLC |
增持 |
19205000 |
12138.14万股 |
0.12% |
好仓 |
2020-07-10 |
| 华领医药-B |
Impresa Fund III Limited Partnership |
减持 |
-12670000 |
8274.49万股 |
0.08% |
好仓 |
2020-07-10 |
| 华领医药-B |
Impresa Management LLC |
减持 |
-12670000 |
8274.49万股 |
0.08% |
好仓 |
2020-07-10 |
| 锦欣生殖 |
China International Capital Corporation (Hong Kong) Limited |
减持 |
-244930000 |
184.40万股 |
0.00% |
好仓 |
2020-07-10 |
| 锦欣生殖 |
China International Capital Corporation Limited |
减持 |
-244930000 |
691.40万股 |
0.00% |
好仓 |
2020-07-10 |
| 罗马元宇宙集团 |
余季华 |
增持 |
9800000 |
2930.00万股 |
0.17% |
好仓 |
2020-07-10 |
| 飞霓控股 |
Golden World Consultants Limited |
减持 |
-257040000 |
0.00万股 |
0.00% |
好仓 |
2020-07-10 |
| 欧康维视生物-B |
Summer Iris Limited |
增持 |
78214230 |
7821.42万股 |
0.14% |
好仓 |
2020-07-10 |
| 欧康维视生物-B |
Boyu Capital General Partner IV, Ltd |
增持 |
78214230 |
7821.42万股 |
0.14% |
好仓 |
2020-07-10 |
| 欧康维视生物-B |
Boyu Capital Fund IV, L.P |
增持 |
78214230 |
7821.42万股 |
0.14% |
好仓 |
2020-07-10 |
